持续气道正压通气在左侧乳腺癌放疗中的心脏保护能力与位置可重复性
研究评估持续气道正压通气(CPAP)在左侧乳腺癌容积旋转调强放疗(VMAT)中的分次间与分次内可重复性及实用性。心脏位置可重复,平均心脏-靶区间距离误差为2.0±2.0 mm;与自由呼吸相比,CPAP显著降低平均心脏剂量及左心室和左前降支剂量。CPAP成功应用于221例(93%),平均心脏剂量为1.6±0.7 Gy。
要点
- 心脏位置可重复,平均心脏-靶区间距离绝对误差为2.0±2.0 mm。
- 与自由呼吸相比,CPAP显著降低平均心脏剂量及左心室和左前降支剂量。
- CPAP成功应用于221例(93%),平均心脏剂量为1.6±0.7 Gy。
核心结论
- CPAP在左侧乳腺癌VMAT中具有足够的心脏保护能力和充分的可重复性,且依从性高,因此适用于左侧乳腺癌放疗的常规实践。
研究设计与样本
- 通过20例左侧乳腺癌患者15次VMAT的20次计划CT和300次每日锥形束CT测量心脏-靶区间距离,评估分次间可重复性。
- 比较CPAP与自由呼吸VMAT计划的全心脏及其亚结构剂量学指标。
- 通过20例非乳腺癌女性患者的4维CT测量乳腺靶区和膈肌运动,评估分次内可重复性。
- 分析237例连续左侧乳腺癌患者(伴或不伴内乳淋巴结照射)的CPAP依从性数据。
主要发现
- 心脏位置可重复,平均心脏-靶区间距离绝对误差为2.0±2.0 mm。
- 与自由呼吸相比,CPAP显著降低平均心脏剂量及左心室和左前降支剂量。
- 乳腺靶区分次内位置变化在内外侧、头脚和前后方向分别为0.5±0.5、2.5±2.0和1.8±1.4 mm。
- CPAP成功应用于221例患者(93%),平均心脏剂量为1.6±0.7 Gy(内乳淋巴结照射:2.0 Gy,无内乳淋巴结照射:1.1 Gy)。
关键数值与推荐
- 心脏位置可重复性以平均心脏-靶区间距离绝对误差2.0±2.0 mm为证据。
- CPAP成功应用率为93%(221/237例)。
- CPAP下平均心脏剂量为1.6±0.7 Gy;内乳淋巴结照射组为2.0 Gy,无内乳淋巴结照射组为1.1 Gy。
临床怎么用
- CPAP适用于左侧乳腺癌放疗的常规实践。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Our purpose was to investigate the interfraction and intrafraction reproducibility and practical applicability of continuous positive airway pressure (CPAP) for left breast volumetric modulated arc therapy (VMAT). METHODS AND MATERIALS: Interfraction reproducibility of the position of the heart was evaluated by measuring the heart-to-target distance on 20 planning computed tomography (CT) and 300 daily cone beam CT of 20 patients with left breast cancer treated with a 15-fraction VMAT. The dosimetric metrics of the whole heart and its substructures were compared between CPAP and free-breathing based VMAT plans. Intrafraction reproducibility was evaluated by measuring the motions of the breast target and diaphragm in 4-dimensional CT of 20 female patients with nonbreast cancer. Lastly, we analyzed the CPAP compliance data of 237 consecutive patients with left-sided breast cancer with and without internal mammary node irradiation (IMNI). RESULTS: The heart position was reproducible as evidenced by an absolute average heart-to-target distance error of 2.0 ± 2.0 mm. Compared with free-breathing, CPAP significantly reduced the mean heart dose and the dose to the left ventricle and left anterior descending artery. The average intrafraction position variation of the breast target was 0.5 ± 0.5, 2.5 ± 2.0, and 1.8 ± 1.4 mm in the mediolateral, craniocaudal, and anteroposterior directions, respectively. CPAP was successfully applied in 221 patients (93%), with a mean heart dose of 1.6 ± 0.7 Gy (IMNI: 2.0 Gy and no IMNI: 1.1 Gy). CONCLUSIONS: CPAP has adequate heart-sparing capability and sufficient reproducibility in VMAT for left-sided breast cancer treatment, with a high compliance rate. Thus, CPAP is applicable in routine practice for left-sided breast cancer radiation therapy.
引用
- Choi MS, Chang JS, Park RH, et al. Heart-Sparing Capability and Positional Reproducibility of Continuous Positive Airway Pressure in Left-Sided Breast Radiation Therapy. Pract Radiat Oncol. 2022. PMID: 35151923. doi:10.1016/j.prro.2021.12.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。